Detalhe da pesquisa
1.
Cobicistat as a Potential Booster of Ponatinib and Dasatinib Exposure in a CML Patient: A Case Study.
Ther Drug Monit
; 45(4): 428-430, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37253456
2.
Optimising pharmacotherapy in older cancer patients with polypharmacy.
Eur J Cancer Care (Engl)
; 29(1): e13185, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31692151
3.
Reversible Impaired Methotrexate Clearance After Platinum-Based Chemotherapy for Osteosarcoma.
Ther Drug Monit
; 41(6): 693-695, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31169759
4.
Amiodarone Rifampicin Drug-Drug Interaction Management With Therapeutic Drug Monitoring.
Ther Drug Monit
; 40(2): 159-161, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29470228
5.
(111)In-trastuzumab scintigraphy in HER2-positive metastatic breast cancer patients remains feasible during trastuzumab treatment.
Mol Imaging
; 13(5)2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24825298
6.
Transcriptomics- and Genomics-Guided Drug Repurposing for the Treatment of Vesicular Hand Eczema.
Pharmaceutics
; 16(4)2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38675137
7.
Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants.
JCO Precis Oncol
; 8: e2300599, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709992
8.
Pharmacokinetic Boosting of Kinase Inhibitors.
Pharmaceutics
; 15(4)2023 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37111635
9.
Representation of older patients in the safety analysis of protein kinase inhibitor registration studies.
J Geriatr Oncol
; 14(8): 101636, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806290
10.
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer.
Target Oncol
; 18(3): 441-450, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081309
11.
Lapatinib and 17AAG reduce 89Zr-trastuzumab-F(ab')2 uptake in SKBR3 tumor xenografts.
Mol Pharm
; 9(11): 2995-3002, 2012 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23003202
12.
Comment on: "CYP3A4*22 GenotypeGuided Dosing of Kinase Inhibitors in Cancer Patients".
Clin Pharmacokinet
; 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38734861
13.
89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment.
J Nucl Med
; 56(1): 63-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25476536
14.
TGF-ß Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET.
J Nucl Med
; 56(9): 1310-4, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26135113
15.
89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients.
Clin Cancer Res
; 20(15): 3945-54, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25085789
16.
Everolimus Reduces (89)Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors.
J Nucl Med
; 55(7): 1087-92, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24790218
17.
Placental growth factor (PlGF)-specific uptake in tumor microenvironment of 89Zr-labeled PlGF antibody RO5323441.
J Nucl Med
; 54(6): 929-35, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23625582
18.
Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake.
Cancer Res
; 73(11): 3347-55, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23580572
19.
Transforming growth factor (TGF)-ß expression and activation mechanisms as potential targets for anti-tumor therapy and tumor imaging.
Pharmacol Ther
; 135(2): 123-32, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22587883
20.
CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy.
Neoplasia
; 14(8): 709-18, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22952424